Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer

Oncology

Volumn 56, Issue 4, 1999, Pages 322-327

  Maehara, Yoshihiko ^a   Kabashima, Akira ^a   Tokunaga, Eriko ^a   Hasuda, Shota ^a   Oki, Eiji ^a   Kakeji, Yoshihiro ^a   Baba, Hideo ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Gastric cancer, recurrence and prognosis; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER INFILTRATION; CANCER RECURRENCE; CANCER SURVIVAL; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR GROWTH; TUMOR IMMUNITY;

AGED; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0033004475     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011986     Document Type: Article

References (43)

1. Jinnai D: Evaluation of extended radical operation for gastric cancer, with regard to lymph node metastasis and follow-up results. Jpn J Cancer Res 1968;3:225-231.
2. Kodama Y, Sugimachi K, Soejima K, Matsusaka T, Inokuchi K: Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981;5:241-248.
3. Maruyama K, Gunvén P, Okabayashi K, Sasako M, Kinoshita T: Lymph node metastases of gastric cancer. Ann Surg 1989;210:596-602.
4. Maehara Y, Oshiro T, Baba H, Ohno S, Kohnoe S, Sugimachi K: Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery 1995;117: 380-385.
5. Maehara Y, Moriguchi S, Kakeji Y, Kohnoe S, Korenaga D, Haraguchi M, Sugimachi K: Pertinen risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991;110:820-823.
6. Hall PA, Levinson DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
7. Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K: Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 1990;66:2012-2016.
8. Maehara Y, OkuyamaT, Moriguchi S, Orita H, Kusumoto H, Korenaga D, Sugimachi K: Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer 1992;70:392-395.
9. Korenaga D, Okamura T, Baba H, Saito A, Sugimachi K: Results of resection of gastric cancer extending to adjacent organs. Br J Surg 1988;75:12-15.
10. Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127-139/Part II. Histological classification of gastric cancer. Jpn J Surg 1981;11:140-145.
11. Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127-139/Part II. Histological classification of gastric cancer. Jpn J Surg 1981;11:140-145.
12. Japanese Research Society for Gastric Cancer: Japanese classification of gastric carcinoma, Engl ed 1. Tokyo, Kanehara, 1995.
13. Kakeji Y, Maehara Y, Adachi Y, Baba H, Mori M, Furusawa M, Sugimachi K: Proliferating activity as a prognostic factor in Borrmann type 4 gastric carcinoma. Br J Cancer 1994;69: 749-753.
14. Gray MR, Hall PA, Nash J, Ansari B, Lane DP, Kingsnorth AN: Epithelial proliferation in Barren's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992;103:1769-1776.
15. Dixon WJ (ed): BMDP Statistical Software. Berkeley, University of California Press, 1988.
16. Cox DR: Regression models and life tables. J R Statist Soc B 1972;34:187-220.
17. Moriguchi S, Maehara Y, Korenaga D, Kakeji Y, Sugimachi K, Nose Y: The relationship between prognostic significance of pathological type and the degree of gastric wall invasion in gastric cancer. Cancer J 1992;5:220-223.
18. Maehara Y, Okuyama T, Moriguchi S, Tsujitani S, Korenaga D, Sugimachi K: Predictors of lymph node metastasis in early gastric cancer. Br J Surg 1992;79:245-247.
19. Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K: Surgical treatment and outcome for node-negative gastric cancer. Surgery 1997;121:633-639.
20. Maeda K, Chung Y-S, Onoda N, Kato Y, Nitta A, Arimoto Y, Yamada N, Kondo Y, Sowa M: Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Cancer 1994;73:528-533.
21. Lee S-H, Hurwitz J: Mechanism of elongation of primed DNA by DNA polymerase 8, proliferating cell nuclear antigen, and activator 1. Proc Natl Acad Sci USA 1990;87:5672-5676.
22. Flores-Rozas H, Kelman Z, Dean FB, Pan Z-Q, Haeper JW, Elledge SJ, O'Donnell M, Hurwitz J: Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase 5 holoenzyme. Proc Natl Acad Sci USA 1994;91:8655-8659.
23. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369:574-578.
24. Yonemura Y, Kimura H, Fushida S, Tugawa K, Nakai Y, Kaji M, Fonseca L, Yamaguchi A, Miyazaki I: Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 1993;71: 2448-2453.
25. Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. I. J Exp Med 1973;137:1142-1162.
26. Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. II. J Exp Med 1974;139:380-397.
27. Nussenzweig MC, Steinman RM, Gutchinov B, Cohn ZA: Dendritic cells are accessory cells for development of anti-trinitrophenyl cytotoxic T-lymphocytes. J Exp Med 1980;152: 1070-1084.
28. Sunshine GH, Katz DR, Feldmann M: Dendritic cells induce T cell proliferation to synthetic antigens under Ir gene control. J Exp Med 1980;152:1817-1822.
29. Black MM, Freeman C, Mork T, Harvei S, Cutler SJ: Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes. Cancer 1971;27:703-711.
30. Watanabe H, Enjoji M, Imai T: Gastric carcinoma with lymphoid stroma; its morphologic and prognostic correlation. Cancer 1976;38: 232-243.
31. Tsujitani S, Furukawa T, Tamada R, Okamura T, Yasumoto K, Sugimachi K: Langerhans' cells and prognosis in patients with gastric carcinoma. Cancer 1987;59:501-505.
32. Furukawa T, Watanabe S, Kodama T, Sato Y, Shimosato Y, Suemasu K: T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis. Cancer 1985;56:2651-2656.
33. Tsujitani S, Okamura T, Baba H, Korenaga D, Haraguchi M, Sugimachi K: Endoscopic intratumoral injection of OK-432 and Langerhans' cells in patients with gastric carcinoma. Cancer 1998;61:1749-1753.
34. Nakano T, Oka K, Arai T, Morita S, Tsunemoto H: Prognostic significance of Langerhans' cell infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med 1989;113:507-511.
35. Ambe K, Mori M, Enjoji M: S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Cancer 1989;63:496-503.
36. Matsuda H, Mori M, Tsujitani S, Ohno S, Kuwano H, Sugimachi K: Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissues. Cancer 1990;65: 2261-2265.
37. Maehara Y, Emi Y, Baba H, Adachi Y, Akazawa K, Ichiyoshi Y, Sugimachi K: Recurrences and related characteristics of gastric cancer. Br J Cancer 1996;74:975-979.
38. Tsujitani S, Kakeji Y, Maehara Y, Sugimachi K, Kaibara N: Dendritic cells prevent lymph node metastasis in patients with gastric cancer. In Vivo 1993;7:233-238.
39. Okuyama T, Maehara Y, Kakeji Y, Tsujitani S, Korenaga D, Sugimachi K: Interrelation between tumor-associated cell surface glycoprotein and host immune response in gastric carcinoma patients. Cancer 1998;82:1468-1475.
40. Maehara Y, Tomisaki S, Oda S, Kakeji Y, Tsujitani S, Ichiyoshi Y, Akazawa K, Sugimachi K: Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. Int J Cancer 1997;74: 224-228.
41. Kekow J, Wiedemann GJ: Transforming growth factor β: A cytokine with multiple actions in oncology and potential clinical applications. Int J Oncol 1995;7:177-182.
42. Tsujitani S, Kakeji Y, Orita H, Watanabe A, Kohnoe S, Baba H, Anai H, Maehara Y, Sugimachi K: Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer. Anticancer Res 1992;12:645-648.
43. Maehara Y, Okuyama T, Kakeji Y, Baba H, Furusawa M, Sugimachi K: Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. Am J Surg 1994;168:36-40.